PAVmed Q4 2025 Adj. EPS $(1.05) Beats $(4.62) Estimate, Sales $52.000K Beat $25.000K Estimate

Benzinga Newsdesk www.benzinga.com Positive 85.8%

Neg 0% Neu 0% Pos 85.8%

Comments

No comments yet. Be the first!